Zydus Lifesciences
Indian multinational pharmaceutical company
Zydus Lifesciences ▸ Facts ▸ Comments ▸ News ▸ Videos
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacture of generic drugs. It ranked 100th in the Fortune India 500 list in 2020.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Zydus 2-dose Covid-19 vaccine gets regulatory nodIndiaTimes - Published | |
DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age groupThe Drug Controller General of India (DCGI) on Tuesday granted emergency use approval to Covid-19 vaccines, Covaxin and Corbevax, for children below 12. Bharat Biotech's Covaxin has got nod for use in..IndiaTimes - Published | |
2-shot Zydus vaccine may be rolled out soonSoon a two-shot Covid-19 vaccine of Zydus LifeSciences could be rolled out, instead of the three-shot regimen currently approved. The company has received approval from the Subject Expert Committee..IndiaTimes - Published | |
Covid-19: Two shot vaccine by Zydus gets SEC nodSoon a two-shot Covid-19 vaccine of Zydus Cadila could be rolled out, instead of the three-shot regimen currently approved. The company has received approval from the Subject Expert Committee (SEC)..IndiaTimes - Published | |
Zydus starts supply of its needle-free 3-dose vaccination to govtPharma major Zydus Cadila said on Wednesday it has started supplying its Covid-19 vaccine ZyCoV-D to the Centre, nearly six months after it had been authorised for emergency use in the 12 and above age..IndiaTimes - Published | |
Zydus starts delivery of needless Covid-19 vaccines to central governmentThe company is also planning to make the vaccine available in the private market.DNA - Published | |
